A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis
← catalyst calendarSponsored by Bristol-Myers Squibb (industry) · BMY — their whole pipeline →.
Phase
Phase 4
Status
Terminated
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
130actual
Sites
31
Countries
Argentina, Canada, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
Business objectives have changed
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-10-09 | actual | When the study began enrolling |
| Primary completion | 2025-04-25 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-04-25 | actual | The whole study's end, after follow-up |
| First posted | 2023-09-21 | actual | When this record first appeared on the registry |
| Results posted | 2026-04-17 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-04-17 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Palmoplantar Psoriasis
- Genital Psoriasis
Interventions
- Drug: Deucravacitinib — also filed as BMS-986165, SOTYKTU
- Drug: Placebo
Primary outcomes
what the primary-completion date above is the date OFPercentage of Participants Achieving Palmoplantar Psoriasis Area and Severity Index (Pp-PASI)-75 Response
measured Week 16
Percentage of Participants Achieving Static Physician's Global Assessment of Genitalia (sPGA-G) Response
measured Week 16
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2023-05-08 · 14.5 MB · Prot_SAP_000.pdf
Permalink · BMY's whole pipeline · Catalyst calendar · Every registered study · What changed